Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $78.69 | $30.83 | 155.26% | 62.45x | 73.89x | 11.44x | 13.04x | 1.30x | $180.28M | 2.20% | $635.79M | 6.11 | $8.20B | 80.22 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $38.64 | $5.83 | 562.39% | 644.00x | 37.27x | 5.36x | 5.78x | 2.71x | $66.49M | 2.34% | $495.01M | 6.74 | $2.68B | 140.79 | ||
| TGTX | TG THERAPEUTICS INC | $34.67 | $14.23 | 143.70% | 84.56x | 46.23x | 11.21x | 19.90x | 1.13x | -$59.24M | -1.17% | $276.43M | 1.88 | $5.62B | 57.66 | ||
| CRMD | CORMEDIX INC | $10.18 | $13.47 | -24.40% | 39.15x | 5.49x | 8.05x | 6.01x | 0.33x | -$13.63M | -2.05% | $114.89M | 1.76 | $624.65M | 35.36 | ||
| HALO | HALOZYME THERAPEUTICS INC | $67.03 | $70.25 | -4.58% | 14.96x | 11.47x | 6.90x | 23.56x | 0.60x | $540.69M | 6.65% | $332.75M | 2.74 | $9.29B | 11.73 | ||
| KRYS | KRYSTAL BIOTECH INC | $190.23 | $87.44 | 117.57% | 37.23x | 38.72x | 15.31x | 5.29x | 1.29x | $185.88M | 3.38% | $1.04B | 36.00 | $5.16B | 29.49 | ||
| RPRX | ROYALTY PHARMA PLC | $37.01 | $51.95 | -28.76% | 16.02x | 8.20x | 6.80x | 2.27x | 0.37x | $2.11B | 13.48% | $9.50B | 22.44 | $28.95B | 22.50 | ||
| ARGX | ARGENX SE | $843.66 | $239.90 | 251.67% | 33.71x | 52.75x | 27,214.84x | 7.18x | 3.64x | $467.72M | 0.91% | $7.17B | 117.50 | $49.09B | 60.51 | ||
| INVA | INNOVIVA INC | $17.27 | $17.80 | -2.99% | 28.31x | 8.72x | 2.93x | 1.52x | 0.47x | $196.35M | 18.08% | $714.82M | 11.37 | $1.14B | 9.08 | ||
| VCEL | VERICEL CORP | $35.32 | $5.48 | 544.36% | 252.29x | 179.56x | 7.14x | 5.81x | 2.93x | -$8.30M | -0.47% | $306.81M | 6.09 | $1.80B | 81.66 | ||
| ADMA | ADMA BIOLOGICS INC | $14.36 | $9.90 | 45.00% | 16.32x | 22.79x | 7.31x | 8.60x | 1.20x | $65.77M | 1.89% | $398.33M | 1.65 | $3.41B | 20.91 | ||
| EXEL | EXELIXIS INC | $39.25 | $27.95 | 40.43% | 18.26x | 16.77x | 4.80x | 5.20x | 1.01x | $754.07M | 7.05% | $2.03B | 7.46 | $10.58B | 12.73 | ||
| GYRE | GYRE THERAPEUTICS INC | $8.30 | $0.42 | 1,873.12% | 207.50x | 63.85x | 7.24x | 8.69x | 17.77x | $73.00k | 0.01% | $92.03M | 1.03 | $764.30M | 77.52 | ||
| INCY | INCYTE CORP | $87.57 | $64.02 | 36.78% | 19.81x | 17.06x | 3.71x | 4.10x | 0.90x | $958.08M | 5.64% | $4.17B | 21.50 | $15.18B | 11.20 | ||
| MDXG | MIMEDX GROUP INC | $6.69 | $4.93 | 35.63% | 30.41x | 23.47x | 2.72x | 4.57x | 0.71x | $57.13M | 5.78% | $216.62M | 1.47 | $889.44M | 16.36 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $25.90 | $38.25 | -32.29% | 8.20x | 8.22x | 1.93x | 1.93x | 0.52x | $258.73M | 17.38% | $773.08M | 13.45 | $1.12B | 4.21 | ||
| TECH | BIO-TECHNE CORP | $61.86 | $20.11 | 207.54% | 131.62x | 35.10x | 7.99x | 5.01x | 1.38x | $256.55M | 2.63% | $1.92B | 12.18 | $9.90B | 45.67 | ||
| VCYT | VERACYTE INC | $35.83 | $10.28 | 248.70% | 83.33x | 40.60x | 6.03x | 2.35x | 1.79x | $78.45M | 2.80% | $1.19B | 15.31 | $2.67B | 42.34 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $53.29 | $42.28 | 26.05% | 15.49x | 14.08x | 3.34x | 1.70x | 0.95x | $694.91M | 6.79% | $6.03B | 31.41 | $9.61B | 10.29 | ||
| GMAB | GENMAB A | $33.17 | $15.16 | 118.86% | 16.83x | 18.83x | 6.41x | 4.01x | 3.89x | $938.44M | 4.41% | $5.30B | 8.26 | $20.12B | 11.07 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $20.55 | $19.36 | 6.15% | 11.88x | 9.38x | 4.49x | 2.94x | 0.88x | $274.72M | 10.94% | $856.03M | 7.01 | $1.86B | 6.01 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $11.55 | $5.08 | 127.42% | 26.25x | 18.78x | 5.99x | 4.53x | 1.83x | $92.38M | 5.93% | $335.30M | 2.49 | $1.55B | 17.91 | ||
| MNKD | MANNKIND CORP | $5.47 | $1.02 | 433.80% | 49.73x | 84.15x | 5.53x | -30.49x | 5.81x | $28.79M | 1.72% | -$55.04M | -0.18 | $1.91B | 24.12 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $416.81 | $139.52 | 198.75% | 29.52x | 26.31x | 9.37x | 6.22x | 2.94x | $3.50B | 3.27% | $17.18B | 66.91 | $103.42B | 22.53 | ||
| UTHR | UNITED THERAPEUTICS CORP | $433.34 | $178.42 | 142.87% | 15.66x | 16.25x | 6.35x | 2.73x | 14.38x | $1.07B | 5.48% | $7.17B | 159.06 | $18.01B | 10.42 | ||
| NVO | NOVO NORDISK A S | $54.37 | $25.17 | 116.02% | 13.96x | 15.02x | 4.99x | 9.26x | 12.35x | $10.18B | 4.19% | $26.22B | 5.87 | $255.37B | 10.44 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.